According to a market report by Lucintel, the future of the antipsychotic drug market in Japan looks promising with opportunities in the schizophrenia, dementia, bipolar disorder, and depression markets. The antipsychotic drug market in Japan is expected to reach an estimated $20.7 billion by 2031, with a CAGR of 5.8% from 2025 to 2031. The major drivers for this market are the rise in prevalence of mental disorders and growing awareness regarding mental health.
A more than 150-page report to understand trends, opportunity and forecast in antipsychotic drug market in Japan to 2031 by therapeutic class (first-generation and second-generation), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and application (schizophrenia, dementia, bipolar disorder, depression, and others).
Download sample by clicking on antipsychotic drug market in Japan
Lucintel forecasts that, within the therapeutic class category, second-generation will remain the larger segment over the forecast period.
Within the application category, schizophrenia will remain the largest segment due to an increase in incidences of schizophrenic disorders.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Antipsychotic Drug Market in India
Antipsychotic Drug Market in Indonesia
Antipsychotic Drug Market in Malaysia
Antipsychotic Drug Market in China
Antipsychotic Drug Market in South Korea
Antipsychotic Drug Market in Thailand